昭衍新药

- 603127

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2021  2020  2019  2018  2017  2016  2015  2014  2013  2012 
昭衍新药(603127) 利润表
单位:万元
报表日期2021-06-302021-03-312020-12-312020-09-302020-06-30
一、营业总收入53,455.6520,099.25107,590.4963,151.3339,735.50
营业收入53,455.6520,099.25107,590.4963,151.3339,735.50
二、营业总成本47,750.8711,132.4980,430.5852,218.3532,706.79
营业成本26,324.889,732.8352,309.2131,714.7419,802.43
营业税金及附加466.45160.54653.51473.69354.95
销售费用725.36319.771,290.73978.57649.06
管理费用13,126.156,710.9620,863.5014,095.359,215.66
财务费用4,921.98-6,779.50247.7467.45-120.78
研发费用2,186.05987.885,065.904,888.552,805.47
资产减值损失----------
公允价值变动收益9,202.9890.255,894.58244.4883.20
投资收益546.35178.71152.37151.15151.15
其中:对联营企业和合营企业的投资收益----------
汇兑收益----------
三、营业利润17,386.6410,780.3536,111.8113,361.488,430.76
加:营业外收入3.470.671.641.430.78
减:营业外支出126.97377.4256.2453.4237.44
其中:非流动资产处置损失----------
四、利润总额17,263.1410,403.6036,057.2113,309.498,394.10
减:所得税费用1,953.811,093.594,694.431,588.78867.74
五、净利润15,309.349,310.0031,362.7811,720.717,526.36
归属于母公司所有者的净利润15,373.499,335.7331,501.3911,828.417,566.48
少数股东损益-64.16-25.72-138.61-107.69-40.12
六、每股收益
基本每股收益(元/股)0.60000.39001.40000.52000.3400
稀释每股收益(元/股)0.59000.38001.39000.52000.3300
七、其他综合收益-236.65-3,071.112,851.123,420.184,213.73
八、综合收益总额15,072.686,238.8934,213.9015,140.8911,740.09
归属于母公司所有者的综合收益总额15,136.846,264.6234,352.5115,248.5811,780.21
归属于少数股东的综合收益总额-64.16-25.72-138.61-107.69-40.12
下载全部历史数据到excel中 返回页顶